THINK Surgical nets up to $65m with Symbiotic Capital debt facility

THINK Surgical has secured up to $65m successful maturation superior aft entering into a indebtedness installation statement with Symbiotic Capital, mounting the institution up with funds to beforehand commercialized activities surrounding its robotics strategy and companion bundle for full genu arthroplasty (TKA) procedures.

Under the agreement, the California-based institution volition get an archetypal $25m, an further $15m predicated connected achieving definite milestones, and up to an further $25m of discretionary capital.

Think's flagship merchandise is TMINI, a handheld robotics strategy for TKA procedures. Ahead of surgery, patients acquisition a CT scan that Think's TPLAN bundle uses to make a 3D exemplary of the patient's joint, allowing surgeons to precisely representation retired the alignment and prime the astir due implant from a scope of shaper options. The strategy is besides utilized during TKA surgery, on with facilitating immoderate indispensable positional adjustments to an implant.

TMINI secured US Food and Drug Administration (FDA) clearance successful July 2024. Ahead of the agency's clearance, Think signed a constricted organisation statement with Zimmer Biomet successful June 2024. The orthopaedics elephantine said astatine the clip that its exertion would beryllium integrated into TMINI.

Meanwhile, Think said astatine the clip that it would proceed moving with further implant partners to proceed selling TMINI arsenic an unfastened level technology. According to Think, TMINI is presently compatible with astir 70% of the marketplace stock for full genu implants.

Think's CEO, Stuart Simpson, said: "This facility, combined with caller further investments by our existing investors, volition let america to proceed our important maturation and improvement of TMINI, and is expected to afloat concern the institution to profitability."

Aside from the indebtedness installation with Symbiotic Capital, Think has antecedently raised astir $300m done a premix of task financing, backstage equity, and equity offerings.

GlobalData investigation reveals that the wide planetary robotic country marketplace is increasing astatine a CAGR of 5.6% and is projected to scope a valuation of astir $20.8bn successful 2035. Meanwhile, a GlobalData marketplace exemplary indicates that Stryker led the orthopaedic surgical robotics marketplace successful 2025 with a 75.5% marketplace share, followed by Smith & Nephew and Zimmer Biomet successful 2nd and 3rd position, with marketplace shares of 10.4% and 9.5%, respectively.

"THINK Surgical nets up to $65m with Symbiotic Capital indebtedness facility" was primitively created and published by Medical Device Network, a GlobalData owned brand.